Mr. Nagel has served as a member of our board of directors since June 2020. He has over 30 years of sales and marketing experience in the medical device industry. Since 2012, Mr. Nagel has served as the President and CEO of Vomaris Innovations, Inc, which specializes in wireless microcurrent-generating technologies that are focused on regeneration, healing, and recovery. Previously, Mr. Nagel served as the Chief Commercial Officer of Neomend, a biomaterial company that developed ProGel, a PMA approved surgical sealant for lung surgery. From 1997 to 2005, Mr. Nagel also served as Co-Founder and Vice President of Worldwide Sales and Marketing at Vascular Solutions (VASC).
In addition to Mr. Nagel’s executive experience, he also serves as a director for Franklin Mountain Medical, LLC an early stage company in the structural heart market. Mr. Nagel holds both a B.A. in Business and a M.B.A. from the University of St. Thomas.
Mr. Bersani has served as a member of our Board since June 2020. The Company appointed Mr. Bersani Chief Executive Officer effective May 10, 2022. From January 2022 to May 2022, Mr. Bersani served as interim Chief Executive Officer. From April 2020 to January 2022, Mr. Bersani was a Partner with B2B CFO Partners, LLC, which provides strategic management advisory services to owners of privately held companies. From November 2019 to March 2020, he served as the President, and Chief Executive Officer of K.P. Diamond Eagle, Inc., a consulting firm specialized in development of innovative commercial and private aviation business models. He served as a Senior Director within Alvarez & Marsal’s Private Equity Performance Improvement Practice, LLP between August 2018 and October 2019. From October 206 to July 2018, he served as President and Chief Executive Officer of K.P. Diamond Eagle, Inc. Prior to those professional experiences, Mr. Bersani served as the Chief Financial Officer of Fuel Systems Solutions, Inc. between April 2011 and October 2016.
Mr. Bersani is a Certified Public Accountant and is also a Certified Public Auditor and a Chartered Certified Accountant in Italy where he developed a significant knowledge of US GAAP and IFRS. Mr. Bersani earned a BA and MA in Business Economics from L. Bocconi University, Italy.
Mr. Catlin has more than 38 years of Information Technology (IT)experience in the finance and aerospace sectors and has served as a member of audit and various risk and security committees. He has experience in cybersecurity, IT operations, IT risk, and software development. He retired from Capital Group as a Senior Vice President at the end of 2022. In addition, he was the Chairperson of the Investment Company Institute Chief Information Security Officer committee.
Mr. Catlin began his career as a software developer, where he gained experience in the development of accounting, financial, and program management systems. After joining Capital Group in 1994, he took on leadership roles with increasing responsibility in Application Development and Infrastructure. As a Senior Vice President, he was Chief Information Security Officer (CISO) and Head of Technology Infrastructure.
Mr. Catlin has been a speaker at various industry forums on cybersecurity, technology, and risk management. He holds an M.S. in Computer Science and a B.S. in Business Computer Methods from the California State University system.
Ms. Misajon recently joined the board of directors in July, 2023. She has extensive experience in the medical device regulated industry at both start-ups and at established public companies. Ms. Misajon currently holds the position of Chief Compliance Officer and Vice President of Regulatory, Quality and Operations at Suneva Medical, Inc. She has held prior executive leadership positions in the areas of Regulatory Affairs, Quality Assurance, and Clinical Studies. Ms. Misajon holds a Bachelor of Arts degree in Management from the University of Phoenix.